Katy Smith
Impact in
-
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
-
- COVID-19 and healthcare impacts
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 3
- Cancer Treatment and Pharmacology 2
- Colorectal Cancer Treatments and Studies 2
- Viral-associated cancers and disorders 1
-
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Bhawna Sirohi (1 shared paper)Martin Kaiser (2 shared papers)Kevin Boyd (2 shared papers)Radovan Sašo (2 shared papers)Sharon West (2 shared papers)Charlotte Pawlyn (2 shared papers)Amit Sud (2 shared papers)Simon Stern (2 shared papers)
- Journals
- Expert Review of Anticancer Therapy (1 paper)The Lancet Haematology (1 paper)European Journal of Cancer (1 paper)Clinical Lymphoma Myeloma & Leukemia (1 paper)Leukemia & lymphoma (1 paper)
- Partner nations
- United KingdomUnited StatesChina
In The Last Decade
Katy Smith
5 papers receiving 96 citations
Peers
Comparison fields: 5 of 23
- Infectious Diseases 54
- Oncology 43
- Hematology 14
- Applied Microbiology and Biotechnology 2
- Health 7
Countries citing papers authored by Katy Smith
This map shows the geographic impact of Katy Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katy Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katy Smith more than expected).
Fields of papers citing papers by Katy Smith
This network shows the impact of papers produced by Katy Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katy Smith. The network helps show where Katy Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Katy Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 75 | |
| 2 | 2008 | 15 | |
| 3 | 1999 | 3 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 1 |
About Katy Smith
Katy Smith is a scholar working on Oncology, Infectious Diseases, Molecular Biology, Pathology and Forensic Medicine and Obstetrics and Gynecology, having authored 5 papers that have together received 96 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (2 papers), Cancer Treatment and Pharmacology (2 papers), Colorectal Cancer Treatments and Studies (2 papers), COVID-19 Impact on Reproduction (1 paper), Angiogenesis and VEGF in Cancer (1 paper), Viral-associated cancers and disorders (1 paper), Immunotherapy and Immune Responses (1 paper) and vaccines and immunoinformatics approaches (1 paper). The work is most often cited by research in Infectious Diseases (54 citations), Oncology (43 citations), Hematology (14 citations), Applied Microbiology and Biotechnology (2 citations) and Health (7 citations). Katy Smith has collaborated with scholars based in United Kingdom, United States and China. Frequent co-authors include Bhawna Sirohi, Martin Kaiser, Kevin Boyd, Radovan Sašo, Sharon West, Charlotte Pawlyn, Amit Sud, Simon Stern, Robyn Shea and Sarah Bird. Their work appears in journals such as Expert Review of Anticancer Therapy, The Lancet Haematology, European Journal of Cancer, Clinical Lymphoma Myeloma & Leukemia and Leukemia & lymphoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.